Compare MYO & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYO | DLHC |
|---|---|---|
| Founded | 2004 | 1969 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.9M | 75.7M |
| IPO Year | 2017 | 2012 |
| Metric | MYO | DLHC |
|---|---|---|
| Price | $1.39 | $4.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 713.1K | 16.2K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,000,000,000.00 | $41,923,000.00 |
| Revenue This Year | $9.10 | N/A |
| Revenue Next Year | $13.59 | $0.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40814.79 | 2.57 |
| 52 Week Low | $0.61 | $4.45 |
| 52 Week High | $1.89 | $8.09 |
| Indicator | MYO | DLHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.18 | 38.05 |
| Support Level | $0.77 | N/A |
| Resistance Level | N/A | $5.50 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 46.24 | 33.97 |
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.